NAN
NANOSONICS FPO [NAN]
Healthcare · ASX Small Cap
$3.3600 -1.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical38
Catalyst71
Sentiment50
Fundamental98
Momentum45
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Sustained volume spike (2.4x median) on DOWN trend
- Cash positive / operating cashflow positive
- Moderate P/S ratio (5.0x)
- Moderate revenue growth (+9%)
- Piotroski F-Score strong (8/9)
- EPS estimates revised upward (+3pts)
- Near 52-week low (11% of range)
- New substantial holder(s) (1)
- Very high short interest (10.6%)
- CANSLIM A: Strong annual earnings CAGR (77%)
- CANSLIM I: Institutional ownership (61%)
- Days to cover very high (50.0)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Earnings declining (-1% QoQ)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Change of Director's Interest Notice
NONE Update - Notification of buy-back - NAN
NONE Update - Notification of buy-back - NAN
HIGH Becoming a substantial holder
LOW 2026 Half Year Financial Results Investor Presentation
Recent ASX Announcements
| 2026-03-02 | Change of Director's Interest Notice |
| 2026-03-01 | Update - Notification of buy-back - NAN |
| 2026-02-26 | Update - Notification of buy-back - NAN |
| 2026-02-26 | Becoming a substantial holder |
| 2026-02-23 | 2026 Half Year Financial Results Investor Presentation |
Key Metrics
$1.0B
Market Cap
641K
Avg Volume
2.4x
Vol Ratio
$3.21 — $5.18
52-Week Range
10.6%
Short Interest
N/A
Cash Runway
10.1%
ROE
9.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | declining | EPS Growth: -1% |
| A | Annual Earnings | pass | CAGR: 77% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 85% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | pass | Inst: 61% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #33 of 119 · Sector avg: 51
View all Healthcare signals →